Trial intelligence / Profile preview

WITHDRAW: Immunomodulator Withdrawal Strategies with Infliximab in Pediatric Crohn's Disease

NCT01802593Phase 4Terminated

Sponsor
Prof. Arie Levine
Start
Feb 2013
Primary completion
Dec 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of azathioprine, methotrexate, mercaptopurine in Crohn's disease, sponsored by Prof. Arie Levine. Started Feb 2013; status: terminated.

02

Drugs

azathioprinemethotrexatemercaptopurine
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT01802593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01802593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call